Search hospitals > Rhode Island > Providence
Rhode Island Hospital Comprehensive Cancer Center
Claim this profileProvidence, Rhode Island 02903
Global Leader in Breast Cancer
Global Leader in Leukemia
Conducts research for Tumors
Conducts research for Cancer
Conducts research for Lymphoma
87 reported clinical trials
21 medical researchers
Summary
Rhode Island Hospital Comprehensive Cancer Center is a medical facility located in Providence, Rhode Island. This center is recognized for care of Breast Cancer, Leukemia, Tumors, Cancer, Lymphoma and other specialties. Rhode Island Hospital Comprehensive Cancer Center is involved with conducting 87 clinical trials across 109 conditions. There are 21 research doctors associated with this hospital, such as Jennifer J. Welch, Benedito Carneiro, Adam J. Olszewski, and Eric Wong, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
2Leukemia
Global LeaderCD19 positive
TP53 positive
Del(17p) positive
Top PIs
Jennifer J. WelchRhode Island Hospital7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
45 reported clinical trials
107 drugs studied
Benedito CarneiroLifespan Cancer Institute2 years of reported clinical research
Studies Solid Tumors
Studies Tumors
11 reported clinical trials
21 drugs studied
Adam J. OlszewskiRhode Island Hospital3 years of reported clinical research
Studies Lymphoma
Studies Mantle Cell Lymphoma
10 reported clinical trials
25 drugs studied
Eric Wong, MDBeth Israel Deaconess Medical Center1 year of reported clinical research
Studies Cancer
Studies Brain Tumor
8 reported clinical trials
15 drugs studied
Clinical Trials running at Rhode Island Hospital Comprehensive Cancer Center
Breast Cancer
Cancer
Non-Hodgkin's Lymphoma
Tumors
Endometrial Cancer
Esophageal Cancer
Solid Tumors
Bladder Cancer
Lymphoma
Sarcoma
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Giredestrant vs. Fulvestrant
for Advanced Breast Cancer
This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.
Recruiting2 awards Phase 38 criteria
DS-1103a + T-DXd
for Advanced Cancer
This study will evaluate the safety and efficacy of DS-1103a combination therapy in patients with advanced solid tumors.
Recruiting1 award Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rhode Island Hospital Comprehensive Cancer Center?
Rhode Island Hospital Comprehensive Cancer Center is a medical facility located in Providence, Rhode Island. This center is recognized for care of Breast Cancer, Leukemia, Tumors, Cancer, Lymphoma and other specialties. Rhode Island Hospital Comprehensive Cancer Center is involved with conducting 87 clinical trials across 109 conditions. There are 21 research doctors associated with this hospital, such as Jennifer J. Welch, Benedito Carneiro, Adam J. Olszewski, and Eric Wong, MD.